Abstract:Dysregulation of mucosal immune system has been proposed to be critical in the pathogenesis of inflammatory bowel diseases (IBDs). Regulatory T cells (Tregs) play an important role in regulating immune responses. Tregs are involved in maintaining intestinal homeostasis and exerting suppressive function in colitis. Our previous studies showed that a novel forkhead box protein P3 (Foxp3) negative Tregs (Treg-of-B cells), induced by culturing naïve CD4+ T cells with B cells, could protect against colitis and downregulate T helper (Th) 1 and Th17 cell cytokines in T cell-mediated colitis. In the present study, we aimed to induce Treg-of-B cells in the CD8+ T-cell population and investigate their characteristics and immunomodulatory functions. Our results showed that CD8+ Treg-of-B cells expressed Treg-associated markers, including lymphocyte-activation gene-3 (LAG3), inducible co-stimulator (ICOS), programmed death-1 (PD-1), cytotoxic T-lymphocyte-associated protein-4 (CTLA-4), tumor necrosis factor receptor superfamily member-4 (TNFRSF4, OX40), and tumor necrosis factor receptor superfamily member-18 (TNFRSF18, GITR), but did not express Foxp3. CD8+ Treg-of-B cells produced higher concentration of inhibitory cytokine interleukin (IL)-10, and expressed higher levels of cytotoxic factor granzyme B and perforin after stimulation, compared to those of CD8+CD25- T cells. Moreover, CD8+ Treg-of-B cells suppressed T cell proliferation in vitro and alleviated colonic inflammation in chronic dextran sulfate sodium (DSS)-induced colitis. In conclusion, our study identified a novel subpopulation of CD8+ Tregs with suppressive effects through cell contact. These CD8+ Treg-of-B cells might have therapeutic potential for IBDs.

The Effect of FOXP3+ Regulatory T Cells on Infectious and Inflammatory Diseases

Molecular Mechanisms Underlying the Regulation and Functional Plasticity of FOXP3 + Regulatory T Cells

Inflammation Negatively Regulates FOXP3 and Regulatory T-cell Function Via DBC1.

The Functional Stability of FOXP3 and RORγt in Treg and Th17 and Their Therapeutic Applications.

The role of FOXP3+ regulatory T cells in human autoimmune and inflammatory diseases

The Molecular Mechanisms of Regulatory T Cell Immunosuppression

Control of Regulatory T Cells and T Helper Cells in Human Diseases: from Bench to Bedside.

Foxp3+ Regulatory T Cells: a Protagonist in the “movie’’ of Autoimmune Diseases?

Epigenetic regulation of human FOXP3+ Tregs: from homeostasis maintenance to pathogen defense

Research Progress on Regulatory T Cells and Their Relationship with Autoimmune Diseases

Molecular and biological role of the FOXP3 N-terminal domain in immune regulation by T regulatory/suppressor cells.

FOXP3<SUP>+</SUP> regulatory T cells and age-related diseases

The regulation of immune tolerance by FOXP3

Tregs: Where We Are and What Comes Next?

The functional regulation of Treg and its role in anti-tumor immunotherapy

Post-Translational Regulations of Foxp3 in Treg Cells and Their Therapeutic Applications

The Secret of FOXP3 Downregulation in the Inflammation Condition.

Induced Foxp3(+) regulatory T cells: a potential new weapon to treat autoimmune and inflammatory diseases?

FOXP3 and RORγt: transcriptional regulation of Treg and Th17.

Current Research in Regulatory T Cell and Inflammatory Bowel Diseases

Characterization of novel CD8+ regulatory T cells and their modulatory effects in murine model of inflammatory bowel disease